Brad Nutter to leave Gambro Healthcare

Brad Nutter to leave Gambro Healthcare Stockholm, Sweden, October 26, 2000 - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that Brad Nutter, President of Gambro Healthcare, has decided to leave his position as of November 1, 2000. Nutter is leaving for personal reasons. Sören Mellstig, President and CEO of Gambro, will serve as acting President of Gambro Healthcare. This means that Larry C. Buckelew, President Gambro Healthcare US, Terry Gilpin, President Gambro Healthcare International, and Kevin Smith, CFO, will report direct to him. "I do regret that I have to take this step", says Brad Nutter. "However, I am pleased with the progress we have made during the year. A new strategy has been established, a new management structure is in place, a new organization is being set up in the US, and we managed to settle the laboratory issue in a very short time. I am confident that we have established a good base for a future good development for Gambro Healthcare." For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8- 613 65 00, +46-70-513 65 33 Cindy Lyman or Kerry Schneider, Citigate Dewe Rogerson, New York , tel. +1-212-688 6840 ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2000/10/26/20001026BIT00230/bit0001.doc http://www.bit.se/bitonline/2000/10/26/20001026BIT00230/bit0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.